SCHEMBL9738675

SCHEMBL9738675

CNC(=O)c1nc(Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)n(CC(C)(C)C)n1

nearest known ligand 0.37

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
SLC33A1 O00400 2/20 0.36
AGTR1 P30556 2/20 0.35
RIPK1 Q13546 1/20 0.34
AGTR2 P50052 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9738544 0.92 SLC33A1 (0.38) SLC33A1AGTR1RIPK1
SCHEMBL9738918 0.91 SLC33A1 (0.34) SLC33A1AGTR1RIPK1
SCHEMBL9738616 0.91 SLC33A1 (0.36) SLC33A1AGTR1RIPK1AGTR2
SCHEMBL9738435 0.91 SLC33A1 (0.37) SLC33A1AGTR1
SCHEMBL9738700 0.89 AGTR1 (0.39) SLC33A1AGTR1
SCHEMBL9739505 0.89 RIPK1 (0.37) SLC33A1RIPK1
SCHEMBL9738294 0.88 AGTR1 (0.43) AGTR1
SCHEMBL9739141 0.88 RIPK1 (0.37) SLC33A1RIPK1
SCHEMBL9738399 0.87 AGTR1 (0.49) AGTR1
SCHEMBL9739869 0.86 AGTR1 (0.36) AGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992005161-A1 1,3,5-TRISUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-04-02 WO claimed
WO-1992005161-A1 1,3,5-TRISUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-04-02 WO disclosed